
南美洲和中美洲免疫诊断市场预测至 2030 年 - 区域分析 - 按产品(酶联免疫吸附测定 (ELISA)、化学发光免疫测定 (CLIA)、放射免疫测定 (RIA) 等)、临床适应症(传染病、肝炎+HIV、内分泌、胃肠、代谢等)和最终用户(医院、诊所、诊断实验室、学术和研究机构等)
No. of Pages: 199 | Report Code: BMIRE00027836 | Category: Life Sciences
No. of Pages: 199 | Report Code: BMIRE00027836 | Category: Life Sciences
对由病毒、真菌、细菌、寄生虫或其感染原引起的几种不断增长的传染病的诊断和管理有毒产品导致免疫诊断测试的处方数量激增,例如补体结合、沉淀测试、凝集测试、线印迹分析、蛋白质印迹分析、酶免疫分析 (EIA) 和免疫荧光测试。
人类免疫缺陷病毒 (HIV) 仍然是全球范围内的主要公共卫生问题。
此外,结核病 (TB)、COVID-19 和其他医院获得性病毒感染(HAIs)需要免疫诊断测试。
• 结核病已成为第 13 大死因,也是仅次于 COVID-19 的第二大传染病杀手。 2020 年,全球有 150 万人死于结核病,估计有 1000 万人受到影响,其中包括 560 万男性、330 万女性和 110 万儿童。
据 Worldometer 称,全球报告了数百万人因 COVID-19 大流行而死亡。它给医疗保健系统带来了压力,并增加了对免疫诊断测试的需求。
诊断在确定合适的医疗方法方面发挥着至关重要的作用。免疫诊断有助于诊断严重影响免疫系统的疾病。因此,传染病患病率的上升导致对免疫诊断产品的需求激增。
根据《2019年世界人口老龄化》报告,2019年巴西65岁以上人口数量为1952.6万人,预计到 2050 年,老年人口数量将达到 5202.6 万人。老年人口的增加预计将提高该国肝癌、结肠癌和胰腺癌的患病率,因为老年人更容易患上这些癌症以及其他慢性疾病,这将随后推动对诊断的需求。细菌和病毒大流行的大规模爆发、对即时诊断的需求不断增加以及技术的快速发展正在进一步推动分子诊断的发展。例如,2020 年 11 月,专注于传染病的领先定点诊断公司 Chembio Diagnostics, Inc. 透露,其子公司 Chembio Diagnostics Brazil Ltda 获得了 Agéncia Nacional de Vigilància Sanitària (ANVISA) 的认可DPP SARS-CoV-2 抗原测试系统在巴西获得批准。在巴西,非传染性疾病也构成了严重的健康问题,占死因的 72%,特别是心血管疾病(31.3%)、癌症(16.3%)、糖尿病(5.2%)和慢性呼吸道疾病(5.8%) )。因此,癌症、糖尿病和其他慢性疾病病例的不断增加,对免疫诊断的需求激增。
南和南中美洲免疫诊断市场细分
南部和中部地区中美洲免疫诊断市场分为产品、临床适应症、最终用户和国家/地区。中美洲免疫诊断市场细分为酶联免疫吸附测定(ELISA)、化学发光免疫测定(CLIA)、放射免疫测定(RIA)等。 2023 年,酶联免疫吸附测定 (ELISA) 领域在南美地区占据最大份额。中美洲免疫诊断市场。化学发光免疫分析(CLIA)细分市场进一步细分为维生素D分析市场、HIV检测市场、HIV ag/ab组合分析市场和其他测试。
基于临床适应症、 南方和中美洲免疫诊断市场细分为传染病、肝炎+HIV、内分泌、胃肠道、代谢等。 2023 年,传染病领域在南美和南美地区所占份额最大。中美洲免疫诊断市场。传染病细分为 COVID-19、结核病、莱姆病、感染管理、寨卡病毒、密螺旋体、火炬、麻疹和腮腺炎、水痘带状疱疹病毒和 EB 病毒。内分泌学领域进一步细分为高血压、生长、糖尿病、甲状腺和生殖内分泌学。
根据最终用户,South &中美洲免疫诊断市场分为医院、诊所、诊断实验室、学术和医疗机构。研究机构等。 2023 年,医院部门在南部和南部地区占据最大份额。中美洲免疫诊断市场。
基于国家、南部和非洲。中美洲免疫诊断市场分为巴西、阿根廷和南美其他地区。中美洲。 2023 年,南部和南部其他地区中美洲地区在南美地区占据最大份额。中美洲免疫诊断市场。
雅培实验室;生物梅里埃公司;丹纳赫公司; DiaSorin SpA; F.霍夫曼-拉罗氏有限公司;珀金埃尔默公司;深圳迈瑞生物医疗电子有限公司;西门子医疗保健有限公司;斯瓦尔生命科学公司;和赛默飞世尔科技公司是在南方和美国运营的一些领先公司。中美洲免疫诊断市场。
Strategic insights for South & Central America Immunodiagnostics involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.
Report Attribute | Details |
---|---|
Market size in 2023 | US$ 955.72 Million |
Market Size by 2030 | US$ 1,648.52 Million |
Global CAGR (2023 - 2030) | 8.1% |
Historical Data | 2021-2022 |
Forecast period | 2024-2030 |
Segments Covered |
By 产品
|
Regions and Countries Covered | 南美洲和中美洲
|
Market leaders and key company profiles |
The regional scope of South & Central America Immunodiagnostics refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.
The South & Central America Immunodiagnostics Market is valued at US$ 955.72 Million in 2023, it is projected to reach US$ 1,648.52 Million by 2030.
As per our report South & Central America Immunodiagnostics Market, the market size is valued at US$ 955.72 Million in 2023, projecting it to reach US$ 1,648.52 Million by 2030. This translates to a CAGR of approximately 8.1% during the forecast period.
The South & Central America Immunodiagnostics Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the South & Central America Immunodiagnostics Market report:
The South & Central America Immunodiagnostics Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The South & Central America Immunodiagnostics Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the South & Central America Immunodiagnostics Market value chain can benefit from the information contained in a comprehensive market report.